• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[新型冠状病毒肺炎疫苗]

[Vaccine against COVID-19].

作者信息

Picazo J J

机构信息

Juan J. Picazo, Catedrático Emérito de Microbiología Médica. Facultad de Medicina. Universidad Complutense de Madrid, Spain.

出版信息

Rev Esp Quimioter. 2021 Dec;34(6):559-598. doi: 10.37201/req/085.2021. Epub 2021 Jun 28.

DOI:10.37201/req/085.2021
PMID:34180617
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8638770/
Abstract

The COVID-19 pandemic has produced a huge health, economic and psychological collapse in our society. Health workers have had to face one of the greatest challenges in history, trying to show the population how to deal with this disease. We have learned that vaccines are the great instrument for the fight against infectious diseases and a large number of them began to appear, not as a product of chance but as a product of the enormous progress experienced in recent years with vaccines against new infectious diseases, against other diseases such as Alzheimer's and especially against cancer. All this knowledge has been applied to this disease. Practitioners lamented the little information available to them when asked questions from patients. This document wanted to be a response to these concerns, with a scientific desire, with evidence that put aside unverified data and hoaxes. Faced with an avalanche of information, most of it without the appropriate "peer review" as indicated in the introduction, any publication becomes obsolete at the time of publication, and we opted for an "online" publication, with the incorporation of versions. This online publication has been published in the documents of Spanish Society of Chemotherapy, at https://seq.es/vacunacion-covid-19.

摘要

新冠疫情给我们的社会带来了巨大的健康、经济和心理冲击。医护人员不得不面对历史上最大的挑战之一,努力向民众展示如何应对这种疾病。我们已经认识到,疫苗是抗击传染病的有力工具,而且大量疫苗开始出现,这并非偶然,而是近年来在针对新型传染病、阿尔茨海默病等其他疾病尤其是癌症的疫苗研发方面取得巨大进展的成果。所有这些知识都已应用于这种疾病。当被患者问及问题时,从业者们感叹他们可获得的信息非常有限。本文件旨在回应这些关切,秉持科学的愿望,提供抛开未经证实的数据和骗局的证据。面对大量信息,如引言中所述,其中大部分未经适当的“同行评审”,任何出版物在出版时就可能过时,因此我们选择了“在线”出版,并纳入不同版本。这份在线出版物已发表在西班牙化疗学会的文件中,网址为https://seq.es/vacunacion-covid-19 。

相似文献

1
[Vaccine against COVID-19].[新型冠状病毒肺炎疫苗]
Rev Esp Quimioter. 2021 Dec;34(6):559-598. doi: 10.37201/req/085.2021. Epub 2021 Jun 28.
2
Vaccines against SARS-CoV-2 variants and future pandemics.针对 SARS-CoV-2 变体和未来大流行的疫苗。
Expert Rev Vaccines. 2022 Oct;21(10):1363-1376. doi: 10.1080/14760584.2022.2110075. Epub 2022 Aug 12.
3
Return-to-work, disabilities and occupational health in the age of COVID-19.新冠疫情时代的重返工作岗位、残疾与职业健康。
Scand J Work Environ Health. 2021 Jul 1;47(5):408-409. doi: 10.5271/sjweh.3960. Epub 2021 May 18.
4
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗:辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
5
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.SARS-CoV-2 变体和 COVID-19 疫苗:当前的挑战与未来策略。
Int Rev Immunol. 2023;42(6):393-414. doi: 10.1080/08830185.2022.2079642. Epub 2022 May 28.
6
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.一种基于三聚体 RBD 的马赛克型 COVID-19 疫苗候选物可诱导针对奥密克戎和其他 SARS-CoV-2 变体的强大中和作用。
Elife. 2022 Aug 25;11:e78633. doi: 10.7554/eLife.78633.
7
Clinical trials and the COVID-19 pandemic.临床试验与新冠疫情
Hell J Nucl Med. 2020 Jan-Apr;23(1):4-5. doi: 10.1967/s002449912014.
8
COVID-19 vaccine effectiveness and variants in Nepal: study protocol for a test-negative case-control study with SARS-CoV-2 genetic sequencing.尼泊尔的 COVID-19 疫苗有效性和变异体:一项使用 SARS-CoV-2 基因测序的病例对照研究方案。
BMJ Open. 2023 Apr 18;13(4):e068334. doi: 10.1136/bmjopen-2022-068334.
9
Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants.针对 SARS-CoV-2 及其变体的多样化疫苗平台。
Expert Rev Vaccines. 2022 Jan;21(1):47-67. doi: 10.1080/14760584.2022.1997601. Epub 2022 Jan 11.
10
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.

引用本文的文献

1
[Bell's palsy following COVID-19 vaccination: A case report].[新冠病毒疫苗接种后贝尔麻痹:一例病例报告]
Neurologia. 2021 Sep;36(7):567-568. doi: 10.1016/j.nrl.2021.04.004. Epub 2021 Apr 12.
2
Concern about the Spread of COVID-19 in Regular Basic Education Teachers When Returning to Face-to-Face Classes.对新冠肺炎疫情在基础教育教师恢复面对面授课时传播情况的担忧。
Behav Sci (Basel). 2023 Apr 20;13(4):346. doi: 10.3390/bs13040346.
3
How much do we care about teacher job insecurity during the pandemic? A bibliometric review.疫情期间我们有多关心教师工作不安定?一项文献计量学综述。
Front Public Health. 2023 Feb 9;11:1098013. doi: 10.3389/fpubh.2023.1098013. eCollection 2023.
4
Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study.古巴阿卜杜拉疫苗:在古巴哈瓦那预防新冠病毒病严重疾病和死亡方面的有效性;一项队列研究。
Lancet Reg Health Am. 2022 Dec;16:100366. doi: 10.1016/j.lana.2022.100366. Epub 2022 Sep 24.
5
Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light.经紫外线灭活的 SARS-CoV-2 的免疫原性。
Arch Virol. 2022 Nov;167(11):2181-2191. doi: 10.1007/s00705-022-05530-7. Epub 2022 Jul 20.
6
How Much Do We Care about Teacher Burnout during the Pandemic: A Bibliometric Review.疫情期间我们有多关注教师倦怠:文献计量学综述。
Int J Environ Res Public Health. 2022 Jun 10;19(12):7134. doi: 10.3390/ijerph19127134.
7
Bell's palsy following COVID-19 vaccination: a case report.新冠病毒疫苗接种后发生的贝尔麻痹:一例病例报告。
Neurologia (Engl Ed). 2021 Sep;36(7):567-568. doi: 10.1016/j.nrleng.2021.04.002. Epub 2021 Jul 22.

本文引用的文献

1
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination.Fab 和 Fc 有助于对 SARS-CoV-2 进行最大程度的保护,采用 Matrix-M 疫苗的 NVX-CoV2373 亚单位疫苗。
Cell Rep Med. 2021 Sep 21;2(9):100405. doi: 10.1016/j.xcrm.2021.100405. Epub 2021 Aug 31.
2
A worldwide assessment of changes in adherence to COVID-19 protective behaviours and hypothesized pandemic fatigue.一项针对 COVID-19 防护行为依从性变化和假设的大流行疲劳的全球评估。
Nat Hum Behav. 2021 Sep;5(9):1145-1160. doi: 10.1038/s41562-021-01181-x. Epub 2021 Aug 3.
3
CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants.新冠康复个体中的CD8 + T细胞反应靶向多种主要新冠病毒流行变体的保守表位。
Open Forum Infect Dis. 2021 Mar 30;8(7):ofab143. doi: 10.1093/ofid/ofab143. eCollection 2021 Jul.
4
Covid-19: Delta variant is now UK's most dominant strain and spreading through schools.新冠疫情:德尔塔毒株现已成为英国最主要的毒株,并在学校中传播。
BMJ. 2021 Jun 4;373:n1445. doi: 10.1136/bmj.n1445.
5
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.辉瑞-BioNTech 新冠疫苗在青少年中的安全性、免疫原性和有效性。
N Engl J Med. 2021 Jul 15;385(3):239-250. doi: 10.1056/NEJMoa2107456. Epub 2021 May 27.
6
COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021.美国疾病预防控制中心报告的 2021 年 1 月 1 日至 4 月 30 日 COVID-19 疫苗突破性感染病例。
MMWR Morb Mortal Wkly Rep. 2021 May 28;70(21):792-793. doi: 10.15585/mmwr.mm7021e3.
7
What scientists know about new, fast-spreading coronavirus variants.科学家们对新出现的、快速传播的新冠病毒变种的了解。
Nature. 2021 Jun;594(7861):19-20. doi: 10.1038/d41586-021-01390-4.
8
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.SARS-CoV-2 感染可诱导人类骨髓浆细胞产生长期存活。
Nature. 2021 Jul;595(7867):421-425. doi: 10.1038/s41586-021-03647-4. Epub 2021 May 24.
9
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.异源初免-加强型新型冠状病毒肺炎疫苗接种:初始反应原性数据
Lancet. 2021 May 29;397(10289):2043-2046. doi: 10.1016/S0140-6736(21)01115-6. Epub 2021 May 12.
10
Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial.卫星V 3期试验中期数据的数据差异及报告不达标
Lancet. 2021 May 22;397(10288):1881-1883. doi: 10.1016/S0140-6736(21)00899-0. Epub 2021 May 12.